NPI: 1255602694 · ROANOKE, VA 24014 · Internal Medicine Physician · NPI assigned 01/17/2012
Authorized official PRESCOTT, ELEANOR controls 20+ related entities in our dataset. Read more
| Authorized Official | PRESCOTT, ELEANOR (GOVERNMENT PROGRAM MANAGER) |
| NPI Enumeration Date | 01/17/2012 |
Other providers sharing the same authorized official: PRESCOTT, ELEANOR
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,280 | $322K |
| 2019 | 29,156 | $1.27M |
| 2020 | 30,371 | $1.34M |
| 2021 | 34,043 | $1.63M |
| 2022 | 49,732 | $2.54M |
| 2023 | 49,009 | $2.50M |
| 2024 | 32,288 | $1.49M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 103,569 | 95,201 | $6.16M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 25,102 | 23,957 | $1.91M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15,467 | 14,457 | $1.21M |
| 87428 | 10,826 | 10,504 | $365K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 18,362 | 17,531 | $238K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 18,073 | 8,599 | $232K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7,731 | 7,557 | $231K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,497 | 1,464 | $181K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,136 | 1,095 | $126K |
| 71046 | Radiologic examination, chest; 2 views | 2,451 | 2,305 | $62K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,487 | 1,430 | $61K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,151 | 1,038 | $58K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,292 | 1,260 | $57K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 370 | 358 | $29K |
| 73630 | 1,041 | 992 | $28K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,215 | 2,060 | $27K |
| 73610 | 885 | 842 | $26K | |
| 73130 | 564 | 538 | $16K | |
| 81003 | 7,454 | 7,013 | $15K | |
| 81025 | 1,425 | 1,344 | $10K | |
| 93000 | 830 | 794 | $10K | |
| 73110 | 248 | 236 | $8K | |
| 99001 | 2,523 | 2,444 | $4K | |
| 87807 | 241 | 224 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 390 | 362 | $3K |
| 73030 | 105 | 102 | $3K | |
| 3078F | 667 | 641 | $3K | |
| 99051 | 765 | 695 | $2K | |
| 3074F | 529 | 512 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,071 | 1,004 | $2K |
| 10060 | 12 | 12 | $1K | |
| 3075F | 211 | 205 | $950.30 | |
| 3079F | 167 | 164 | $925.90 | |
| 3077F | 174 | 170 | $901.15 | |
| 12001 | 17 | 12 | $899.94 | |
| 73564 | 16 | 14 | $646.70 | |
| 3080F | 79 | 77 | $500.25 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 97 | 89 | $460.03 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 39 | 37 | $444.57 |
| 74018 | 14 | 14 | $368.36 | |
| 3044F | 79 | 77 | $350.00 | |
| 73140 | 12 | 12 | $329.09 | |
| 69209 | 12 | 12 | $190.01 | |
| 86308 | 25 | 25 | $137.30 | |
| 82962 | 32 | 29 | $117.63 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 15 | 13 | $74.02 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 25 | 24 | $33.56 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 203 | 185 | $27.51 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 27 | 27 | $1.85 |
| 1125F | 77 | 77 | $0.00 | |
| 1126F | 45 | 45 | $0.00 | |
| 1159F | 1,034 | 1,006 | $0.00 |